XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Impact of ASC 326 Adoption
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Impact of ASC 326 Adoption
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period (in shares) at Dec. 31, 2021     7,180,155        
Balance in the beginning of period at Dec. 31, 2021 $ 298,150   $ 60,233 $ 1,814 $ 239,876   $ (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,392       7,392    
Stock incentive plan 63     63      
Issuance of shares of common stock as board compensation (in shares)     675        
Issuance of shares of common stock as board compensation 35   $ 35        
Repurchase of common stock under stock repurchase program (in shares)     (4,465)        
Repurchase of common stock under stock repurchase program (218)   $ (218)        
Cash dividend (502)       (502)    
Other comprehensive income (loss) (40,046)           (40,046)
Balance at the end of period (in shares) at Mar. 31, 2022     7,176,365        
Balance at the end of period at Mar. 31, 2022 264,874   $ 60,050 1,877 246,766   (43,819)
Balance at the beginning of period (in shares) at Dec. 31, 2021     7,180,155        
Balance in the beginning of period at Dec. 31, 2021 298,150   $ 60,233 1,814 239,876   (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 16,539            
Other comprehensive income (loss) (60,031)            
Balance at the end of period (in shares) at Jun. 30, 2022     7,176,365        
Balance at the end of period at Jun. 30, 2022 253,596   $ 60,050 1,940 255,410   (63,804)
Balance at the beginning of period (in shares) at Dec. 31, 2021     7,180,155        
Balance in the beginning of period at Dec. 31, 2021 $ 298,150   $ 60,233 1,814 239,876   (3,773)
Balance at the end of period (in shares) at Dec. 31, 2022 7,183,915   7,183,915        
Balance at the end of period at Dec. 31, 2022 $ 265,753 $ (569) $ 60,050 2,088 274,781 $ (569) (71,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]            
Balance at the beginning of period (in shares) at Mar. 31, 2022     7,176,365        
Balance in the beginning of period at Mar. 31, 2022 $ 264,874   $ 60,050 1,877 246,766   (43,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 9,147       9,147    
Stock incentive plan 63     63      
Cash dividend (503)       (503)    
Other comprehensive income (loss) (19,985)           (19,985)
Balance at the end of period (in shares) at Jun. 30, 2022     7,176,365        
Balance at the end of period at Jun. 30, 2022 $ 253,596   $ 60,050 1,940 255,410   (63,804)
Balance at the beginning of period (in shares) at Dec. 31, 2022 7,183,915   7,183,915        
Balance in the beginning of period at Dec. 31, 2022 $ 265,753 (569) $ 60,050 2,088 274,781 (569) (71,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 9,598       9,598 (569)  
Stock incentive plan 69     69      
Forfeiture of restricted shares of common stock (in shares)     (1,130)        
Issuance of shares of common stock as board compensation (in shares)     1,660        
Issuance of shares of common stock as board compensation 84   $ 84        
Repurchase of common stock under stock repurchase program (in shares)     (6,795)        
Repurchase of common stock under stock repurchase program (346)   $ (346)        
Cash dividend (574)       (574)    
Other comprehensive income (loss) 2,625           2,625
Balance at the end of period (in shares) at Mar. 31, 2023     7,177,650        
Balance at the end of period at Mar. 31, 2023 $ 276,640   $ 59,788 2,157 283,236   (68,541)
Balance at the beginning of period (in shares) at Dec. 31, 2022 7,183,915   7,183,915        
Balance in the beginning of period at Dec. 31, 2022 $ 265,753 $ (569) $ 60,050 2,088 274,781 (569) (71,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 18,566         $ (569)  
Repurchase of common stock under stock repurchase program (in shares) (18,689)            
Repurchase of common stock under stock repurchase program $ (947)            
Other comprehensive income (loss) $ 1,473            
Balance at the end of period (in shares) at Jun. 30, 2023 7,175,056   7,175,056        
Balance at the end of period at Jun. 30, 2023 $ 283,372   $ 59,187 2,248 291,630   (69,693)
Balance at the beginning of period (in shares) at Mar. 31, 2023     7,177,650        
Balance in the beginning of period at Mar. 31, 2023 276,640   $ 59,788 2,157 283,236   (68,541)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,968       8,968    
Stock incentive plan $ 91     91      
Issuance of restricted shares of common stock through stock incentive plan (in shares)     9,300        
Repurchase of common stock under stock repurchase program (in shares) (11,894)   (11,894)        
Repurchase of common stock under stock repurchase program $ (601)   $ (601)        
Cash dividend (574)       (574)    
Other comprehensive income (loss) $ (1,152)           (1,152)
Balance at the end of period (in shares) at Jun. 30, 2023 7,175,056   7,175,056        
Balance at the end of period at Jun. 30, 2023 $ 283,372   $ 59,187 $ 2,248 $ 291,630   $ (69,693)